BAM
AXLA

Belpointe Asset Management’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Belpointe Asset Management’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-46
Closed -$549 – 3655
2023
Q1 		$549 Hold
46
– – ﹤0.01% 3579
2022
Q4 		$374 Buy
+46
New +$1.19K ﹤0.01% 3577

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Belpointe Asset Management's AXLA Position: Q2 2023 in Review

Belpointe Asset Management sold out of Axcella Health Inc. Common Stock (AXLA) in Q2 2023, closing a stake of 46 shares — an estimated $549 sold.

Belpointe Asset Management first reported a position in AXLA in Q4 2022 and held it in 2 quarters. The position peaked at $549 in Q1 2023. 28 funds tracked by Wall St. Rank hold AXLA as of Q2 2023.

  • Belpointe Asset Management reported no remaining Axcella Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 46 Axcella Health Inc. Common Stock shares in Q2 2023, an estimated $549.
  • Belpointe Asset Management first reported a position in Axcella Health Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Axcella Health Inc. Common Stock position peaked at $549 in Q1 2023.
  • 28 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.